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Purpose: The purpose of this work was to explore the association between carotid
plaque volume (total and the subcomponents) and cerebral microbleeds (CMBs).
Materials and Methods: Seventy-two consecutive (male 53; median age 64) pa-
tients were retrospectively analyzed. Carotid arteries were studied by using a 16-
detector-row computed tomography scanner whereas brain was explored with a
1.5 Tesla system. CMBs were studied using a T2*-weighted gradient-recalled echo
sequence. CMBs were classified as from absent (grade 1) to severe (grade 4). Com-
ponent types of the carotid plaque were defined according to the following Hounsfield
unit (HU) ranges: lipid less than 60 HU; fibrous tissue from 60 to 130 HU; calci-
fication greater than 130HU, and plaque volumes of each component were calculated.
Each carotid artery was analyzed by 2 observers. Results: The prevalence of CMBs
was 35.3%. A statistically significant difference was observed between symptom-
atic (40%) and asymptomatic (11%) patients (P value = .001; OR = 6.07). Linear
regression analysis demonstrated an association between the number of CMBs
and the symptoms (P = .0018). Receiver operating characteristics curve analysis
found an association between the carotid plaque subcomponents and CMBs (Az = .608,
.621, and .615 for calcified, lipid, and mixed components, respectively), and Mann–
Whitney test confirmed this association in particular for the lipid components (P
value = .0267). Conclusions: Results of this study confirm the association between
CMBs and symptoms and that there is an increased number of CMBs in symp-
tomatic patients. Moreover, we found that an increased volume of the fatty component
is associated with the presence and number of CMBs. Key Words: Cerebral
microbleeds—carotid artery plaque—MRI—CTA.
© 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Introduction
Cerebral microbleeds (CMBs) are small and round
hypointense areas on T2*-weighted gradient-recalled echo
(GRE) sequence.1 In the last years, an increasing inter-
est in the clinical relevance of CMBs in individuals with
cerebrovascular disease or dementia as well as in normal
aging has been manifested,2-4 and it has been suggested
that CMBs may be a reliable biomarker for pathologic
damage to small vessels from hypertension or cerebral
amyloid angiopathy.5 Moreover, CMBs are a common
finding in stroke patients, especially those with hemor-
rhage, and some authors thought that they may be a
marker of future cerebral hemorrhage.6
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Recently Saba et al7 found that there is an association
between the presence of carotid artery fatty plaque and
CMBs by suggesting that the composition of carotid artery
may be considered as a marker of the presence of
CMBs.
Recent investigations demonstrated that the com-
puted tomography angiography (CTA), other than the
quantification of the degree of stenosis and the charac-
terization of the plaque’s morphology, can evaluate the
volume of the total volume of the carotid artery plaque
as well as the volume of the subcomponents of the plaque
(namely the fatty, mixed, and calcified tissues).8,9
The purpose of this work was to assess the potential
association between carotid plaque volume (total and the
subcomponents) and CMBs.
Materials and Methods
Study Design and Patient Population
The institutional review board approval for this study
was obtained. Based on a power calculation (type I error,
α = .05; type II error, β = .1; Az null hypothesis value = .5;
Az significant value = .7, pooled group), we estimated that
a sample size of at least 100 carotids would be suffi-
cient to investigate the relationship between carotid artery
plaque type and CMBs. Therefore, we included all the
patients who underwent multidetector CTA (MDCTA) of
supra-aortic vessels and brain magnetic resonance imaging
(MRI) in our hospital from July 2010 to March 2011 for
a total of 72 consecutive patients (53 male, 19 female; mean
age 68 years; age range 48-83 years).
Part of the examined population (n = 34) was in-
cluded in previously published studies [Blinded for peer
review], and the criteria we adopted to perform MDCTA
of carotid arteries and brain MRI were published in pre-
vious investigations [Blinded for peer review].10,11
In brief, in our institutions, MDCTA of carotid arter-
ies is performed in 2 different types of patients: (1)
symptomatic and (2) asymptomatic. The classification of
the symptomatic patients is described in the next section
whereas asymptomatic patients are recruited from those
patients where screening ultrasound analysis of carotid
arteries showed the following: (1) presence of a carotid
stenosis greater than 50% (according to the NASCET [North
American Symptomatic Carotid Endarterectomy Trial]
criteria12); (2) evidence of plaque alteration (an irregular
surface, intraplaque hemorrhage, ulceration); and (3) when
ultrasound could not provide adequate information about
the degree of stenosis and plaque type because of ana-
tomical conditions. In our institute is protocol to assess
the carotid arteries of asymptomatic patients who undergo
cardiac interventions for coronary artery disease, aortic
interventions, and lower leg artery surgery, and in dia-
betics aged more than 50 years. All patients that perform
CTA of carotid arteries are invited to underwent MRI exam
of the brain. The brain MRI is also performed, as pro-
tocol, in all patients candidates to the carotid
endarterectomy (CEA) procedure.
Classification of Cerebrovascular Symptoms
Vascular risk factors and coexisting comorbidities and
treatment known before stroke or transient ischemic attack
(TIA) are systematically recorded in our institution, and
the TOAST (Trial of Org 10172 in Acute Stroke Treat-
ment) criteria were used to classify the causes of stroke.13
Patients were considered as symptomatic when they suf-
fered TIA or stroke. In this study, we considered 3 months
for the time window to be included in the symptomatic
group.
For the purpose of this analysis, we considered as in-
dependent unit the carotid and the cerebral hemisphere
of each side, and in symptomatic patients we consid-
ered the ipsilateral carotid artery and brain hemisphere
as “symptomatic” and the contralateral carotid artery and
brain hemisphere as “asymptomatic.” In asymptomatic
patients, we considered both carotids and brain hemi-
spheres as “asymptomatic.” Therefore, in symptomatic
patients, according to the clinical symptoms, we consid-
ered a symptomatic side and an asymptomatic side
whereas in asymptomatic patients both sides were con-
sidered asymptomatic.
MDCTA Technique
All patients underwent MDCTA of the supra-aortic
vessels with a 16-multidetector-row computed tomogra-
phy (CT) system (Philips Brilliance, Eindhoven,
Netherlands), according to a previously described meth-
odology [Blinded for peer review].10,11 Examination was
performed from the aortic arch to the carotid siphon by
delivering a bolus of 80 mL of contrast medium (Ultravist
370; Bayer, Leverkusen, Germany) at a flow rate of 5 mL/
s. The correct timing of the scan was selected with a bolus
tracking technique. CT technical parameters included the
following: matrix 512 × 512; field of view (FOV) 14-
19 cm; 180-220 mAs; 120-140 kV. C-filter algorithm was
applied.
Brain MRI Technique
Imaging examinations were performed with a Gyroscan
1.5-T superconducting magnet (Philips, Best, The Neth-
erlands) with a head coil, according to a standardized
protocol [Blinded for peer review]. For each patient, a
two-dimensional T2*-weighted GRE sequence was per-
formed (repetition time (TR) shortest; echo time (TE) 23ms;
flip angle 15°; in-plane resolution .9 × .9 mm; FOV 230mm;
matrix 512 × 512; slice thickness 5mm; interslice gap .5mm).
Definition and Rating of CMBs
All datasets were anonymized and 2 experienced ra-
diologists reviewed in consensus all images for the presence
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of CMBs. Observers considered CMBs as small (<10 mm)
rounded areas of low signal intensity according to
Jeerakathil et al14 (Fig 1).
CMBs were classified for each cerebral hemisphere ac-
cording to Lee and colleagues15 as absent (grade 1), mild
(grade 2; total number of microbleeds, 1-2),moderate (grade
3; total number of microbleeds, 3-10), and severe (grade
4; total number of microbleeds, >10).
Volume of the Plaque and Its Components
To semiautomatically quantify different plaque com-
ponents at the CT images, as described previously,8,9 the
polymeasure plug-in for the software package ImageJ
(Rasband, National Institute of Mental Health, Bethesda,
MD) was used. With this software, voxels identifying lipids
were less than 60 HU (Hounsfield unit), fibrous tissue was
between 60 and 130 HU, and calcium tissue was greater
than 130 HU9 (Fig 2).
Statistical Analysis
In this study, continuous data were described as the
mean value ± standard deviation. Receiver operating char-
acteristics (ROC) curve analysis was performed between
volume (and volume subcomponents: fatty, mixed, and
calcified tissue) and the presence of CMBs. The normal-
ity of each continuous variable group was tested using
the Kolmogorov–Smirnov Z test and different values in
groups with and without CMBs were compared using
the Mann–Whitney test. A P value <.05 was regarded to
indicate statistical significance association, and all values
were calculated using a two-tailed significance level. Sta-
tistical analysis was performed with the SPSS 13.0 statistical
package (SPSS Inc., Chicago, IL). Graphics were plotted
with MedCalc 15.0 software (MedCalc, Mariakerke,
Belgium).
Results
General Results
Four patients were excluded from this study for sub-
optimal image quality due to the presence of dental
hardware. Moreover, we excluded from the analysis 11
carotid arteries because no evidence of an atheroscle-
rotic plaque was found. Therefore, the number of carotid
arteries and consequently cerebral hemispheres in-
cluded in the analysis was 125.
Of the 68 patients, we observed 32 subjects with isch-
emic symptoms (10 strokes, 21 TIAs, 1 amaurosis fugax).
The 11 carotid arteries we excluded were contralateral
to the cerebrovascular symptoms; therefore, 32 symp-
tomatic carotid arteries\brain hemispheres and 93
asymptomatic carotid arteries\brain hemispheres were
studied. In Table 1, the general characteristics of the plaque,
their subcomponents volume, and the percentages are
summarized.
The prevalence of the CMBs was 23.5% (16 of 68); in
15 patients we found CMBs in both hemispheres, and
in 1 patient in only 1 hemisphere. From these data, it is
derived that we had 31 hemispheres with CMBs and 105
hemispheres without CMBs. By considering the pa-
tients, a statistically significant difference was observed
between symptomatic (40%) and asymptomatic (11%) pa-
tients (P value = .001; OR = 6.07), and these data were
confirmed also by considering each hemisphere (symp-
tomatic = 51.4%; asymptomatic = 14.5%; P value = .001;
OR = 7.94). By considering the 125 units of
carotid\hemisphere, we had 29 hemispheres with CMBs
(in 2 cases of the 11 excluded there were CMBs).
ROC Curve Analysis
The ROC curve analysis for total plaque\lipid
components\mixed components\calcified components
volume versus the presence of CMBs is given in Figure 3,
A. In Table 2, the general ROC results from the volume
Figure 1. A 67-year-old male patient with TIA who underwent MRI (same
as in Fig 2). The T2*-weighted GRE is given in panel (A) and panel (B)
with CMBs indicated by the white arrows. Abbreviations: CMBs, cere-
bral microbleeds; GRE, gradient-recalled echo; MRI, magnetic resonance
imaging; TIA, transient ischemic attack.
Figure 2. A 67-year-old male patient with TIA who underwent CTA (same
as in Fig 1). Multiple contiguous slice of right internal carotid artery is
given with the automated segmentation performed by polymeasure (panels
A-H). The white arrow indicates the internal carotid arteries. The legend
of the chromatic scale is as follows: green = opacified lumen; red = fatty
component; yellow = mixed component; blue = calcified component. Abbre-
viations: CTA, computed tomography angiography; TIA, transient ischemic
attack. (Color version of figure is available online.)
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analysis are summarized. The best ROC area under the
curve (Az) was obtained with the lipid component with
a value of .621 (P value = .0258).
The ROC curve analysis was also performed for the
percentage of lipid\mixed\calcified plaque components
versus the presence of CMBs, and the ROC plot is given
in Figure 3, B. In Table 2, the general ROC results from
the volume analysis are summarized. In no cases, the ROC
curve analysis showed a statistically significant associa-
tion between the presence of CMBs and the increased
percentage of lipid\mixed\calcified tissues of the plaque.
In Tables 3 and 4, the results from the Mann–Whitney
test that compared the total plaque volume, the subcom-
ponents volume, and the percentage in the groups with
Table 1. Summary table of carotid artery plaque components
Mean 95% CI SD RSD Median 2.5-97.5 P
Plaque volume 856.38 747,577-965,183 604.4835 .7059 678 188.525-2541.000
Lipid volume 200.397 164,149-236,644 201.3808 1.0049 125 9.525-852.375
Mixed volume 501.579 443,391-559,766 323.2766 .6445 439 113.925-1391.000
Calcium volume 169.248 136,749-201,747 180.5546 1.0668 106 .000-762.075
Lipid percentage 20.868 18,959-22,777 10.6058 .5082 18 4.525-44.000
Mixed percentage 61.793 59,810-63,777 11.0211 .1784 61 35.575-79.425
Calcium percentage 17.264 15,706-18,823 8.6581 .5015 16 .000-35.000
Abbreviations: CI, confidence interval; P, percentiles; RSD, relative standard deviation; SD, standard deviation.
Figure 3. ROC curve analysis of the volume components of the carotid artery plaque according to the presence or absence of cerebral microbleeds (A),
and ROC curve analysis of the percentages of the components according to the presence or absence of cerebral microbleeds (B). Abbreviation: ROC, re-
ceiver operating characteristics.
Table 2. ROC curve analysis volume and percentage
Total plaque volume Lipid volume Mixed volume Calcium volume
Volume Area under the ROC curve .608 .621 .615 .51
Standard error .055 .054 .054 .058
95% confidence interval .516-.696 .528-.707 .522-.702 .418-.602
Significance level P* (area = .5) .0473 .0258 .0342 .8566
Percentage Area under the ROC curve NC .597 .534 .587
Standard error NC .055 .059 .058
95% confidence interval NC .504-.685 .441-.626 .494-.676
Significance level P* (area = .5) NC .0778 .5567 .1362
Abbreviations: NC, not calculable; ROC, receiver operating characteristics.
*P value < .05.
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and without CMBs are summarized. These results are
plotted in Figure 4, A,B.
Discussion
CMBs are frequent findings in MRI scans of elderly
subjects, and according to the MRI protocols applied, in-
cidental CMBs are detected in 4.7%-24.4% of community-
based subjects.16 Moreover, the rates reported for various
types of ischemic strokes and intracerebral hemor-
rhages vary between 19.4% and 68.5%.16,17 This condition
has gained particular consideration in the last years because
studies have demonstrated that it is associated with the
presence and outcome of cerebral strokes and with
neurodegenerative disorders.18-20
Some recent papers have indicated an association
between the atherosclerotic disease of the carotid artery
and the presence of CMBs,7,21,22 and Saba et al7 found that
the presence and the degree of severity of CMBs are as-
sociated with the presence of some specific plaque
subcomponents, namely the fatty components. The purpose
of our study was to explore the potential association
between the carotid artery plaque volume (and the volume
of its subcomponents) and the CMBs.
In our population, we considered the cerebral hemi-
sphere as independent unit, and we observed that, when
CMBs were found, in most cases both hemispheres were
interested (in 15 patients we found CMBs in both hemi-
spheres and in 1 patient in only 1 hemisphere). This finding
Table 3. Summary table for plaque composition in patients with and without CMBs
Mean 95% CI SD RSD Median 2.5-97.5 P K–S test
With
CMBs
Calcium percentage 16.51 14,812-18,209 8.3829 .5077 15 .000-35.1 .181
Lipid percentage 22.198 20,111-24,285 10.3014 .4641 21.5 8.500-43.1 .082
Mixed percentage 61.031 58,881-63,182 10.6133 .1739 61 34.000-78.3 .576
Calcium volume 157.823 127,147-188,499 151.396 .9593 109 .000-566 0
Lipid volume 217.917 176,866-258,968 202.602 .9297 147.5 19.900-858 0
Mixed volume 534.167 465,856-602,477 337.139 .6312 471 98.900-1406.9 0
Plaque volume 902.844 778,950-1,026,738 611.463 .6773 743.5 207.900-2565.1 0
Without
CMBs
Calcium percentage 19.25 16,053-22,447 9.4487 .4908 17.5 1.200-40.2 .53
Lipid percentage 18.778 15,124-22,432 10.7998 .5751 18 2.000-49.4 .004
Mixed percentage 62.528 58,541-66,514 11.7825 .1884 63 38.000-84.6 .9
Calcium volume 194.306 115,042-273,569 234.263 1.2056 88.5 5.600-923 0
Lipid volume 158.889 93,852-223,926 192.218 1.2098 78.5 3.600-770 0
Mixed volume 402.167 318,800-485,533 246.39 .6127 310.5 114.200-965 .06
Plaque volume 710.667 529,362-891,971 535.847 .754 456 180.400-2058 .003
Abbreviations: CI, confidence interval; CMBs, cerebral microbleeds; K–S test, Kolmogorov–Smirnov test; P, percentiles; RSD, relative
standard deviation; SD, standard deviation.
Table 4. Mann–Whitney test
Without CMBs versus with CMBs P value
Calcium percentage .1222
Lipid percentage .058
Mixed percentage .4823
Calcium volume .7572
Lipid volume .0267
Mixed volume .034
Plaque volume .0438
Abbreviation: CMBs, cerebral microbleeds.
Figure 4. Box plot of the volume components of
the carotid artery plaque according to the pres-
ence or absence of CMBs (A), and box plot of the
percentages of the components according to the pres-
ence or absence of CMBs (B). Abbreviation: CMBs,
cerebral microbleeds.
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is concordant with previously published papers23,24 that
showed that the CMBs usually involve both hemi-
spheres. The prevalence of CMBs we found was 23.5%
(16 of 68), and it is similar to other previously pub-
lished papers.16,21-24 However, some recent papers have
reported a very high prevalence of CMBs.25,26 This dif-
ference can be explained by the fact that the detection
of CMBs is reliant on the paramagnetic property of he-
mosiderin which disrupts the local magnetic field (the
so-called “susceptibility effect”) on T2*-weighted GRE.27
But newer MRI techniques, susceptibility-weighted imaging,
and its variants greatly increase the sensitivity of CMBs
detection by combining both the magnitude and the phase
images to increase susceptibility-related tissue contrast.28
In the analysis of our population, we found a statis-
tically significant difference between symptomatic (40%)
and asymptomatic (11%) patients (P value = .001; OR= 6.07),
and these data were confirmed also by considering each
hemisphere (symptomatic = 51.4%; asymptomatic = 14.5%;
P value = .001; OR = 7.94). These data are concordant with
previous observation that found an association between
the presence of cerebral stroke and CMBs.29,30
By focusing our attention on the relationship between
carotid artery plaque volume and CMBs, we found that
the volume of the components (fatty-mixed-calcified)
showed a statistically significant area under the curve,
and the best value was obtained by the lipid compo-
nents (Az = .621; P value = .0258). These results confirm
that there is an association between the status of the carotid
artery and the presence of CMBs. This can be explained
with a common underlying process that interacts with
atherosclerosis that involves carotid arteries as well as
atherosclerosis at the level of the microvessel, which are
damages and allow blood to leak outside the vessels. In
a recent paper by Shimoyama et al,31 an association was
found between CMBs and systemic atherosclerosis in a
population of 105 patients.
When the effect of the percentages of the subcompo-
nents was assessed, it is interesting to observe that there
is no statistically significant association (Table 2). This is
an interesting point in our opinion, because this aspect
represents a significant difference compared to the local
effect of atherosclerosis at the level of carotid arteries where
the percentage of lipid components (and not only the
volume) seems to be a trigger toward the plaque’s
vulnerability.32
The Mann–Whitney test assessed also the total plaque
volume, the subcomponents volume, and the percent-
age in the groups with and without CMBs, and we found
that there is a statistically significant difference in volume
of all the subcomponents with the most important value
in the lipid components.
In this study, there are some limitations. First, some
plaques may have changed their structure composition
during the interval between the magnetic resonance (MR)
analysis and CTA; however, we think that the limited
number of days between MR and CT should reduce this
effect. Second, our findings are based on a relatively small
group of patients, and our data need confirmation in larger
studies in other populations at risk and should be con-
sidered as preliminary results.
Conclusion
In conclusion, the results of this study confirm the as-
sociation between CMBs and symptoms, and that there
is an increased number of CMBs in symptomatic pa-
tients. Moreover, we found that an increased volume of
the fatty component is associated with the presence and
number of CMBs.
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